Mental health status prior to bladder cancer surgery can indicate risk of complications
12/18/2015
A patient's mental health prior to surgery can influence postoperative outcomes.
Multiple myeloma drug could revolutionize treatment for sickle cell disease
12/18/2015
Clinical trial to build on research revealing mechanism of action for FDA-approved pomalidomide; drug reduces faulty hemoglobin in red blood cells from patients with sickle cell disease.
Patients younger than 50 diagnosed with non-small-cell lung cancer (NSCLC) had a higher likelihood of having a targetable genomic alteration for which therapies exist, according to an article...
Pinpoint targeting instead of shotgun approach
12/18/2015
Selective integrin ligand may facilitate specifically attacking cancer cells.Integrins help cells communicate with and adapt to their environment.
Immuno & targeted therapy provide new options for difficult-to-treat head & neck cancer
12/18/2015
Phase I trial reports that pembrolizumab is active in nasopharyngeal cancer. Afatinib is effective as second-line treatment in squamous cell carcinoma of the head and neck in a Phase II study.
NYU nursing study examines obesity in relation to breast cancer related lymphedema
12/18/2015
Lymphedema expert Dr. Mei R. Fu looks to mitigate risk of post-surgery comorbidities through patient education and awareness counseling.Each year, about 1.
Experiments explain the events behind molecular 'bomb' seen in cancer cells
12/18/2015
Since scientists have begun sequencing the genome of cancer cells, they have noticed a curious pattern.
Probing the mystery of how cancer cells die
12/18/2015
Study traces how enigmatic molecules -- said to be named for the riddle-telling sphinx -- help cancer self-destruct.You've probably never heard of 'sphingolipids' before.
Can cocoa help kidney patients?
12/18/2015
Cocoa flavinols are known to have a beneficial effect on the circulatory system; it seems they could help patients with kidney failure, often linked to cardiovascular problems.
New reversible drug shows early promise in preventing dangerous clots
12/17/2015
A uniquely acting antiplatelet agent, PZ-128, appears to be safe and fast for preventing blood clots and its effects are reversible, reducing risk for excessive bleeding.